PREVALENCE TREATMENT OUTCOME AND DRUG SUSCEPTIBILITY PATTERN FOR MULTIDRUG RESISTANT TUBERCULOSIS PATIENTS IN THE SOUTHERN REGION OF KHYBER PAKHTUNKHWA PAKISTAN

http://dx.doi.org/10.31703/gdddr.2022(VII-II).08      10.31703/gdddr.2022(VII-II).08      Published : Jun 2
Authored by : Faisal Younis , Muhammad Nadeem , Sajad Ahmad , Husnian Hashim , Raheela Bano

08 Pages : 59-67

References

  • Ahmad, N., Javaid, A., Syed Sulaiman, S. A., Basit, A., Afridi, A. K., Jaber, A. A. S., & Khan, A. H. (2016). Effects of multidrug-resistant tuberculosis treatment on patients' health related quality of life: results from a follow up study. PloS one, 11(7), 159-560.
  • Akhtar, A. M., Arif, M. A., Kanwal, S., & Majeed, S. (2016). Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan. J Pak Med Assoc, 66(8), 989-3.
  • Ali, S., Khan, M. T., Khan, A. S., Mohammad, N., Khan, M. M., Ahmad, S., ... & Hassan, F. (2020). Prevalence of multi-drug resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa–a high tuberculosis endemic area of Pakistan. Polish Journal of Microbiology, 69(2), 133-137.
  • Atif, M., Bashir, A., Ahmad, N., Fatima, R. K., Saba, S., & Scahill, S. (2017). Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. BMC infectious diseases, 17(1), 1-12.
  • Ejaz, M., Siddiqui, A. R., Rafiq, Y., Malik, F., Channa, A., Mangi, R., ... & Hasan, R. (2010). Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Transactions of the Royal Society of Tropical Medicine and Hygiene, 104(8), 511-517.
  • Khan, I., Ahmad, N., Khan, S., Muhammad, S., Khan, S. A., Ahmad, I., ... & Atif, M. (2019a). Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan. Journal of infection and public health, 12(6), 809-815.
  • Khan, M. A., Mehreen, S., Basit, A., Khan, R. A., Jan, F., Ullah, I., ... & Javaid, A. (2015). Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan. Saudi medical journal, 36(12), 1463-1470.
  • Khan, R. A., Shaikh, A. A., & Bulaadi, G. Q. (2019b). Incidence of multidrug-resistant tuberculosis in Sindh, Pakistan. Cureus, 11(4), 1-15.
  • Kumar, A., Singh, A. K., Upadhyay, V., & Pandey, J. (2018). Epidemiology of multi-drug- resistant tuberculosis in Northern India. Biomedical and Biotechnology Research Journal (BBRJ), 2(2), 112-120
  • Mitnick, C. D., Rodriguez, C. A., Hatton, M. L., Brigden, G., Cobelens, F., Grobusch, M. P., ... & RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative). (2016). Programmatic management of drug-resistant tuberculosis: an updated research agenda. PLoS One, 11(5), 155-968.

References

  • Ahmad, N., Javaid, A., Syed Sulaiman, S. A., Basit, A., Afridi, A. K., Jaber, A. A. S., & Khan, A. H. (2016). Effects of multidrug-resistant tuberculosis treatment on patients' health related quality of life: results from a follow up study. PloS one, 11(7), 159-560.
  • Akhtar, A. M., Arif, M. A., Kanwal, S., & Majeed, S. (2016). Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan. J Pak Med Assoc, 66(8), 989-3.
  • Ali, S., Khan, M. T., Khan, A. S., Mohammad, N., Khan, M. M., Ahmad, S., ... & Hassan, F. (2020). Prevalence of multi-drug resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa–a high tuberculosis endemic area of Pakistan. Polish Journal of Microbiology, 69(2), 133-137.
  • Atif, M., Bashir, A., Ahmad, N., Fatima, R. K., Saba, S., & Scahill, S. (2017). Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. BMC infectious diseases, 17(1), 1-12.
  • Ejaz, M., Siddiqui, A. R., Rafiq, Y., Malik, F., Channa, A., Mangi, R., ... & Hasan, R. (2010). Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Transactions of the Royal Society of Tropical Medicine and Hygiene, 104(8), 511-517.
  • Khan, I., Ahmad, N., Khan, S., Muhammad, S., Khan, S. A., Ahmad, I., ... & Atif, M. (2019a). Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan. Journal of infection and public health, 12(6), 809-815.
  • Khan, M. A., Mehreen, S., Basit, A., Khan, R. A., Jan, F., Ullah, I., ... & Javaid, A. (2015). Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan. Saudi medical journal, 36(12), 1463-1470.
  • Khan, R. A., Shaikh, A. A., & Bulaadi, G. Q. (2019b). Incidence of multidrug-resistant tuberculosis in Sindh, Pakistan. Cureus, 11(4), 1-15.
  • Kumar, A., Singh, A. K., Upadhyay, V., & Pandey, J. (2018). Epidemiology of multi-drug- resistant tuberculosis in Northern India. Biomedical and Biotechnology Research Journal (BBRJ), 2(2), 112-120
  • Mitnick, C. D., Rodriguez, C. A., Hatton, M. L., Brigden, G., Cobelens, F., Grobusch, M. P., ... & RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative). (2016). Programmatic management of drug-resistant tuberculosis: an updated research agenda. PLoS One, 11(5), 155-968.

Cite this article

APA

    APA : Younis, F., Nadeem, M., & Ahmad, S. (2022). Prevalence, Treatment, Outcome, and Drug Susceptibility Pattern for Multi-Drug Resistant Tuberculosis Patients in the Southern Region of Khyber Pakhtunkhwa, Pakistan. Global Drug Design & Development Review, VII(II), 59-67. https://doi.org/10.31703/gdddr.2022(VII-II).08

CHICAGO

    CHICAGO : Younis, Faisal, Muhammad Nadeem, and Sajad Ahmad. 2022. "Prevalence, Treatment, Outcome, and Drug Susceptibility Pattern for Multi-Drug Resistant Tuberculosis Patients in the Southern Region of Khyber Pakhtunkhwa, Pakistan." Global Drug Design & Development Review, VII (II): 59-67 doi: 10.31703/gdddr.2022(VII-II).08

HARVARD

    HARVARD : YOUNIS, F., NADEEM, M. & AHMAD, S. 2022. Prevalence, Treatment, Outcome, and Drug Susceptibility Pattern for Multi-Drug Resistant Tuberculosis Patients in the Southern Region of Khyber Pakhtunkhwa, Pakistan. Global Drug Design & Development Review, VII, 59-67.

MHRA

    MHRA : Younis, Faisal, Muhammad Nadeem, and Sajad Ahmad. 2022. "Prevalence, Treatment, Outcome, and Drug Susceptibility Pattern for Multi-Drug Resistant Tuberculosis Patients in the Southern Region of Khyber Pakhtunkhwa, Pakistan." Global Drug Design & Development Review, VII: 59-67

MLA

    MLA : Younis, Faisal, Muhammad Nadeem, and Sajad Ahmad. "Prevalence, Treatment, Outcome, and Drug Susceptibility Pattern for Multi-Drug Resistant Tuberculosis Patients in the Southern Region of Khyber Pakhtunkhwa, Pakistan." Global Drug Design & Development Review, VII.II (2022): 59-67 Print.

OXFORD

    OXFORD : Younis, Faisal, Nadeem, Muhammad, and Ahmad, Sajad (2022), "Prevalence, Treatment, Outcome, and Drug Susceptibility Pattern for Multi-Drug Resistant Tuberculosis Patients in the Southern Region of Khyber Pakhtunkhwa, Pakistan", Global Drug Design & Development Review, VII (II), 59-67

TURABIAN

    TURABIAN : Younis, Faisal, Muhammad Nadeem, and Sajad Ahmad. "Prevalence, Treatment, Outcome, and Drug Susceptibility Pattern for Multi-Drug Resistant Tuberculosis Patients in the Southern Region of Khyber Pakhtunkhwa, Pakistan." Global Drug Design & Development Review VII, no. II (2022): 59-67. https://doi.org/10.31703/gdddr.2022(VII-II).08